Kura Oncology (KURA) Non-Current Debt (2014 - 2026)
Kura Oncology's Non-Current Debt came in at $5.57 million for Q2 2026, down 14.4% from $6.51 million a year earlier and down 42.8% from the prior quarter.
Powered by 
Analysis
Kura Oncology (KURA) Non-Current Debt (2014 - 2026) Analysis & Trends
At the end of FY2025, Kura Oncology's Non-Current Debt was $9.71 million, up 40.4% from FY2024.
- Non-Current Debt carries a five-year compound annual growth rate of 18.0% (FY2020 to FY2025).
- Going back by year, Non-Current Debt was $6.92 million in FY2024 (-25.9%), $9.33 million in FY2023 (+1.9%) and $9.16 million in FY2022.
- The five-year range for quarterly Non-Current Debt is $5.34 million (Q3 2025) to $9.75 million (Q1 2026).
- Year-over-year, Non-Current Debt increased in two of the last eight quarters, with an average decline of 7.8%.
- The fastest year-over-year change in Non-Current Debt over five years came in Q4 2025 (growth of 40.4%), and the weakest in Q3 2025 (a decline of 31.2%).
- Business Quant data shows KURA's Non-Current Debt at $9.75 million (Q1 2026), $9.71 million (Q4 2025) and $5.34 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 37.34 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 62.48 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 51.08 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -108.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 51.86 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 23.83 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 60.50 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Kura Oncology | 952.70 Mn | 952.70 Mn | 20.63 Mn | 5.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.57 Mn |
| Mar 31, 2026 | 9.75 Mn |
| Dec 31, 2025 | 9.71 Mn |
| Sep 30, 2025 | 5.34 Mn |
| Jun 30, 2025 | 6.51 Mn |
| Mar 31, 2025 | 7.65 Mn |
| Dec 31, 2024 | 6.92 Mn |
| Sep 30, 2024 | 7.76 Mn |
| Jun 30, 2024 | 8.58 Mn |
| Mar 31, 2024 | 9.38 Mn |
| Dec 31, 2023 | 9.33 Mn |
| Sep 30, 2023 | 9.29 Mn |
| Jun 30, 2023 | 9.24 Mn |
| Mar 31, 2023 | 9.20 Mn |
| Dec 31, 2022 | 9.16 Mn |
| Mar 31, 2021 | 3.50 Mn |
| Dec 31, 2020 | 4.25 Mn |
| Sep 30, 2020 | 5.00 Mn |
| Jun 30, 2020 | 5.75 Mn |
| Mar 31, 2020 | 6.50 Mn |
API Access
Kura Oncology Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=KURA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "KURA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=KURA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();